Monday, August 27, 2018

FDA Singles Out Three Drug Substances to Not be Compounded

Regulatory Focus-10 hours ago
Vasopressin, meanwhile, is the active ingredient in Vasostrict, and was the subject of Endo's lawsuit over how the FDA regulates drug compounding.
FDA Says No Need to Compound from Bumetanide, Nicardipine ...
Pharmaceutical Technology Magazine-7 hours ago

No comments: